Deloitte February 12, 2021

Exploring lessons learned from the technology sector

What will health look like in 2040? And how might technology-driven convergence help accelerate innovation in the life sciences? Discover how life sciences organizations can leverage insights from other industries who have converged to capitalize and power innovation, thrive amid uncertainty, and leapfrog the standard of care available to most patients.

Reimagining life sciences business models by 2040

Health in 2040 will be a world apart from what we have now. Our future of biopharma and future of medtech predictions project accelerated change across multiple industry use cases and the potential for completely disrupted business models. In our report, we outline ways for...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Technology
Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.
Report: Prices for top Medicare Part D drugs nearly doubled since entering the market
High cost of weight loss drugs drives employers to require nutrition counseling, in boost for startups
Announcement: Andreessen Horowitz Partners with Lilly to Launch First-of-Its-Kind Biotech Ecosystem Fund
Boosting biopharma R&D performance with a next-generation technology stack

Share This Article